Chang Lisa | TaiRx, Inc. | New Drug Development

About Chang Lisa

This author has not yet filled in any details.
So far Chang Lisa has created 52 blog entries.

TaiRx received the Bronze Award at the 2015 Taipei Biotech Award Competition.

2015/7/24 Bio@Taipei […]

TaiRx received the Bronze Award at the 2015 Taipei Biotech Award Competition. Chang Lisa 2021-02-17T13:48:45+00:00

CVM-1118 IND approved by the US FDA to initiate Phase I clinical study in US.

2015/5/13 CVM-1118 from TaiRx, Inc. receives US FDA approval to initiate Phase I clinical study. TaiRx’s IND application received its approval in 30 days [...]

CVM-1118 IND approved by the US FDA to initiate Phase I clinical study in US. Chang Lisa 2018-06-04T17:51:46+00:00

TaiRx signed research contract with Northwestern University Ann & Robert H. Lurie Children’s Hospital of Chicago to evaluate Nodal, a novel oncology target

2014/3/14 […]

TaiRx signed research contract with Northwestern University Ann & Robert H. Lurie Children’s Hospital of Chicago to evaluate Nodal, a novel oncology target Chang Lisa 2018-06-04T17:51:53+00:00

TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year.

2014/1/10 MoneyDJ […]

TaiRx starts Phase 1 clinical study in the United States and plans to IPO in Taiwan Emerging Stock Market next year. Chang Lisa 2021-02-17T13:53:31+00:00

Industrial Bank of Taiwan, China Development Industrial Bank, Daiwa Securities Group Inc., and Diamond BioFund Inc. raise over ten billion NTD for Biotech.

2013/12/2 […]

Industrial Bank of Taiwan, China Development Industrial Bank, Daiwa Securities Group Inc., and Diamond BioFund Inc. raise over ten billion NTD for Biotech. Chang Lisa 2021-02-17T14:29:53+00:00

Previous 23